secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0000950170-22-014775
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health Q2 revenue up 34% to $670M, adjusted EBITDA turns positive at $7M
-------------------------------------------------------------------------------

- Revenue $670M (+34% YoY); normalized growth 42% excluding prior-year retroactive contract.
- Net loss narrowed to $21M from $299M loss in Q2 2021 which included $275M non-cash stock comp.
- Medical margin $82M (+49% YoY), 12.2% of revenue vs 11.1% a year ago.
- Total members on platform 351,700; MA membership up 44% YoY, same-geography growth 13%.
- FY 2022 guidance: revenue $2.615-2.635B, adjusted EBITDA $0-10M, total members 345-355K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000095017022014775/0000950170-22-014775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000095017022014775/agl-20220804.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-014775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer